1
|
Chopin T, Yarish C, Wilkes R, Belyea E, Lu
S and Mathieson A: Developing Porphyra/salmon integrated
aquaculture or bioremediation and diversification of the
aquaculture industry. J Appl Phycol. 11:463–472. 1999. View Article : Google Scholar
|
2
|
Kwon MJ and Nam TJ: Porphyran induces
apoptosis related signal pathway in AGS gastric cancer cell lines.
Life Sci. 79:1956–1962. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Shin ES, Hwang HJ, Kim IH and Nam TJ: A
glycoprotein from Porphyra yezoensis produces anti-inflammatory
effects in liposaccharide-stimulated macrophages via the TLR4
signaling pathway. Int J Mol Med. 28:809–815. 2011.PubMed/NCBI
|
4
|
Liu F, Liu J, Zhang L, Shen W, Guo T, Liu
C and He P: Ex vivo anti-oxidation activity of polysaccharides from
the red alga Porphyra yezoensis. Res J Pharmacol. 1:61–66.
2007.
|
5
|
Suetsuna K: Purification and
identification of angiotensin I-converting enzyme inhibitors from
the red alga Porphyra yezoensis. J Mar Biotechnol. 6:163–167.
1998.PubMed/NCBI
|
6
|
Lee AV and Yee D: Insulin-like growth
factor and breast cancer. Biomed Pharmacother. 49:415–421. 1995.
View Article : Google Scholar
|
7
|
Butler AA, Yakar S, Gewolb IH, Karas M,
Okubo Y and LeRoith D: Insulin-like growth factor-I receptor signal
transduction: at the interface between physiology and cell biology.
Comp Biochem Physiol B Biochem Mol Biol. 121:19–26. 1998.
View Article : Google Scholar
|
8
|
Guvakova MA and Surmacz E: Tamoxifen
interferes with the insulin-like growth factor I receptor (IGF-IR)
signaling pathway in breast cancer cells. Cancer Res. 57:2606–2610.
1997.PubMed/NCBI
|
9
|
Pelicci G, Lanfrancone L, Salcini AE, et
al: Constitutive phosphorylation of Shc proteins in human tumors.
Oncogene. 11:899–907. 1995.PubMed/NCBI
|
10
|
Habib T, Herrera R and Decker SJ:
Activators of protein kinase C stimulate association of Shc and the
PEST tyrosine phosphatase. J Biol Chem. 269:25243–25246.
1994.PubMed/NCBI
|
11
|
Rhodes CJ and White MF: Molecular insights
into insulin action and secretion. Eur J Clin Invest. 32:3–13.
2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Annunziata M, Cranata R and Ghigo E: The
IGF system. Acta Diabetol. 48:1–9. 2011. View Article : Google Scholar
|
13
|
Krasilnikov MA: Phosphatidylinositol-3
kinase dependent pathways: the role in control of cell growth,
survival, and malignant transformation. Biochemistry (Mosc).
65:59–67. 2000.
|
14
|
Latres E, Amini AR, Amini AA, et al:
Insulin-like growth factor-1 (IGF-1) inversely regulates
atrophy-induced genes via the phosphatidylinositol
3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.
J Biol Chem. 280:2737–2744. 2005. View Article : Google Scholar
|
15
|
Guha M and Mackman N: The
phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide
activation of signaling pathways and expression of inflammatory
mediators in human monocytic cells. J Biol Chem. 277:32124–32132.
2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Junttila MR, Li SP and Westermarck J:
Phosphatase-mediated crosstalk between MAPK signaling pathways in
the regulation of cell survival. FASEB J. 22:954–965. 2008.
View Article : Google Scholar
|
18
|
Roux PP and Blenis J: ERK and p38
MAPK-activated protein kinases: a family of protein kinases with
diverse biological functions. Microbiol Mol Biol Rev. 68:320–344.
2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Weston GR and Davis RJ: The JNK signal
transduction pathway. Curr Opin Cell Biol. 19:142–149. 2007.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Karin M, Liu ZG and Zandi E: AP-1 function
and regulation. Curr Opin Cell Biol. 9:240–246. 1997. View Article : Google Scholar : PubMed/NCBI
|
21
|
Karin M: The regulation of AP-1 activity
by mitogen-activated protein kinases. J Biol Chem. 270:16483–16486.
1995. View Article : Google Scholar : PubMed/NCBI
|
22
|
Shaulian E and Karin M: AP-1 in cell
proliferation and survival. Oncogene. 20:2390–2400. 2001.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Marais R, Wynne J and Treisman R: The SRF
accessory protein Elk-1 contains a growth factor regulated
transcription activation domain. Cell. 73:381–393. 1993. View Article : Google Scholar : PubMed/NCBI
|
24
|
Gopalakrishnan A, Xu CJ, Nair SS, Chen C,
Hebbar V and Kong AN: Modulation of activator protein-1 (AP-1) and
MAPK pathway by flavonoids in human prostate cancer PC3 cells. Arch
Pharm Res. 29:633–644. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Song SH, Kim IH and Nam TJ: Effect of a
hot water extract of Chlorella vulgaris on proliferation of IEC-6
cells. Int J Mol Med. 29:741–746. 2012.PubMed/NCBI
|
26
|
Bancroft C, Chen Z, Yeh J, et al: Effects
of pharmacologic antagonists of epidermal growth factor receptor,
PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and
IL-8 and VEGF expression in human head and neck squamous cell
carcinoma lines. Int J Cancer. 99:538–548. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Gómez-Ordóñez E, Jiménez-Escrig A and
Rupérez P: Effect of the red seaweed Mastocarpus stellatus intake
on lipid metabolism and antioxidant status in healthy Wistar rats.
Food Chem. 135:806–811. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ronghai H, Haile M and Xinzheng L:
Ultrasonic extraction of polysaccharides from Porphyra yezoensis
and their inhibition effects in U937 cell growth. Trans CSAE.
21:165–168. 2005.
|
29
|
Costa LS, Fidelis GPL, Cordeiro SL, et al:
Biological activities of sulfated polysaccharides from tropical
seaweeds. Biomed Pharmacother. 64:21–28. 2010. View Article : Google Scholar
|
30
|
Wang Y, Hailey J, Williams D, et al:
Inhibition of insulin-like growth factor-I receptor (IGF-IR)
signaling and tumor cell growth by a fully human neutralizing
anti-IGF-IR antibody. Mol Cancer Ther. 4:1214–1221. 2005.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Starkman B, Cravero J, Delcarlo M and
Loeser R: IGF-I stimulation of proteoglycan synthesis by
chondrocytes requires activation of the PI3-Kinase pathway but not
ERK MAPK. Biochem J. 389:723–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
33
|
Ballif BA and Blenis J: Molecular
mechanisms mediating mammalian mitogen-activated protein kinase
(MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ.
12:397–408. 2001.PubMed/NCBI
|
34
|
Rubinfeld H and Seger R: The ERK cascade:
a prototype of MAPK signaling. Mol Biotechnol. 31:151–174. 2005.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Meloche S and Pouysségur J: The ERK1/2
mitogen-activated protein kinase pathway as a master regulator of
the G1- to S-phase transition. Oncogene. 26:3227–3239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Davis RJ: Signal transduction by the JNK
group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
|
37
|
Go H, Hwang HJ and Nam TJ: Glycoprotein
extraction from Laminaria japonica promotes IEC-6 cell
proliferation. Int J Mol Med. 24:819–824. 2009.PubMed/NCBI
|
38
|
Kapeller R and Cantley LC:
Phosphatidylinositol 3-kinase. Bioessays. 16:565–576. 1994.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Carpenter CL, Duckworth B, Auger K, Cohen
B, Schaffhausen B and Cantley LC: Purification and characterization
of phosphoinositide 3-kinase from rat liver. J Biol Chem.
265:19704–19711. 1990.PubMed/NCBI
|
40
|
Morgan S and Grandis JR: ErbB receptors in
the biology and pathology of the aerodigestive tract. Exp Cell Res.
315:572–582. 2009. View Article : Google Scholar :
|
41
|
Jiang BH, Aoki M, Zheng JZ, Li J and Vogt
PK: Myogenic signaling of phosphatidylinositol 3-kinase requires
the serine-threonine kinase Akt/protein kinase B. Proc Natl Acad
Sci USA. 96:2077–2081. 1999. View Article : Google Scholar : PubMed/NCBI
|
42
|
Qiu Q, Yang M, Tsang BK and Gruslin A:
EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves
activation of both PI3K and MAPK signalling pathways. Reproduction.
128:355–363. 2004. View Article : Google Scholar : PubMed/NCBI
|
43
|
Lavarone C, Catania A, Marinissen MJ,
Visconti R, Acunzo M, Tarantio C, et al: The platelet-derived
growth factor controls c-myc expression through a JNK-and
AP-1-dependent signaling pathway. J Biol Chem. 278:50024–50030.
2003. View Article : Google Scholar
|
44
|
Monje P, Marinissen MJ and Gutkind JS:
Phosphorylation of the carboxyl-terminal transactivation domain of
c-Fos by extracellular signal-regulated kinase mediates the
transcriptional activation of AP-1 and cellular transformation
induced by platelet-derived growth factor. Mol Cell Biol.
23:7030–7043. 2003. View Article : Google Scholar : PubMed/NCBI
|